Atai Life Sciences Inventory 2020-2025 | ATAI

Atai Life Sciences inventory from 2020 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.
Atai Life Sciences Annual Inventory
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
Atai Life Sciences Quarterly Inventory
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.413B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.115B 18.84
Encompass Health (EHC) United States $11.985B 25.41
DaVita (DVA) United States $10.433B 14.67
Chemed (CHE) United States $8.332B 26.19
Elanco Animal Health (ELAN) United States $6.288B 13.47
Option Care Health (OPCH) United States $5.143B 22.93
RadNet (RDNT) United States $4.247B 269.57
Amedisys (AMED) United States $3.066B 20.62
LifeStance Health (LFST) United States $2.135B 0.00
Addus HomeCare (ADUS) United States $2.064B 22.66
Astrana Health (ASTH) United States $1.362B 33.74
U.S Physical Therapy (USPH) United States $1.123B 28.98
Aveanna Healthcare Holdings (AVAH) United States $1.038B 59.11
Pennant (PNTG) United States $0.957B 35.15
MEDIROM Healthcare Technologies (MRM) Japan $0.043B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00